Výsledky vyhledávání - "R M, Goldberg"

Do Clerkship Experiences Affect Medical Studentsʼ Attitudes toward Chronically Ill Patients?

Autor: R M Goldberg, Olle Jane Z. Sahler, David Nelson, Beth Ellen Davis, Fredrick A. McCurdy, Larrie Greenberg

Publikováno v: Academic Medicine. 76:815-820

Purpose. To measure changes in medical students’ attitudes toward chronically ill patients, and to identify experiences, specifically during clerkships, that contributed to students’ attitudes. Method. A cohort of students from five U.S. medical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6805ecbde45eeaa3ff888bad053acbe5
https://doi.org/10.1097/00001888-200108000-00015

Zobrazit plný text záznamu

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803

Autor: Robert S. Warren, R. M. Goldberg, Leonard B. Saltz, Chloe E. Atreya, Monica M. Bertagnolli, Marlene B. Zuraek, David B. Donner, Robert J. Mayer, Carolyn C. Compton, Cynthia Ye, Vivian Weinberg, Donna Niedzwiecki

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 19(20)

Purpose: The TP53 tumor suppressor is frequently mutated in colon cancer, but the influence of such mutations on survival remains controversial. We investigated whether mutations in the DNA-binding domain of TP53 are associated with survival in stage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b85554b9b8a128f8c85eac2cc8dc441
https://pubmed.ncbi.nlm.nih.gov/23983256

Zobrazit plný text záznamu

Learning preference and personality type: their association in paediatric residents

Autor: R Foley, R M Goldberg, Larrie Greenberg

Publikováno v: Medical Education. 30:307-311

SUMMARY The objective of this study was to determine if there is a relationship between the learning preferences and personality types of residents in paediatrics. As part of a study to teach residents in paediatrics how to teach, the authors adminis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::721672e3d97ea893cf69d823460fe594
https://doi.org/10.1111/j.1365-2923.1996.tb00835.x

Zobrazit plný text záznamu

Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803

Autor: Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Alexander Hantel, Paul L. Schaefer, Al B. Benson, R. M. Goldberg, Nadine Jackson McCleary, Renaud Whittom, Leonard B. Saltz

Publikováno v: Cancer. 116(4)

Cigarette smoking has been shown to increase the risk of developing colorectal cancer, particularly smoking early in life. Little is known about the impact of tobacco use on colon cancer recurrence among colon cancer survivors.The authors prospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d7151d6f5446536277a23395b8fe8d1
https://pubmed.ncbi.nlm.nih.gov/20052723

Zobrazit plný text záznamu

Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

Autor: Heinz-Josef Lenz, Alan P. Venook, John R. Taylor, Susan Sutherland, Donna Hollis, R. M. Goldberg, Donna Niedzwiecki, Charles D. Blanke

Publikováno v: Clinical colorectal cancer. 6(7)

The management of patients with metastatic colorectal cancer (CRC) has changed dramatically over the past 5 years. The availability of new cytotoxic and biologic treatment agents, namely irinotecan, oxaliplatin, capecitabine, bevacizumab, cetuximab,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ad60a48330d1535c46ddf7e9d3d5a6
https://pubmed.ncbi.nlm.nih.gov/17553204

Zobrazit plný text záznamu

Review article: colorectal cancer chemotherapy

Autor: S, Gill, R R, Thomas, R M, Goldberg

Publikováno v: Alimentary pharmacologytherapeutics. 18(7)

Colorectal cancer is a leading cause of cancer death world-wide. There have been important advances in the chemotherapeutic management of colorectal cancer as a result of a deliberate collaborative process of well-designed clinical trials. From the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f60840787b7d66dad446ccf1dc2d2c46
https://pubmed.ncbi.nlm.nih.gov/14510741

Zobrazit plný text záznamu

Future directions in adjuvant therapy for stage III colon carcinoma

Autor: H C, Pitot, R M, Goldberg

Publikováno v: Oncology (Williston Park, N.Y.). 15(3 Suppl 5)

The current recommendation for adjuvant chemotherapy for patients with newly diagnosed stage III colon cancer involves 6 months of fluorouracil (5-FU) plus low- or high-dose leucovorin. In clinical trials performed throughout the world, several drugs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::25e93244fbcaa56321f3c888813cdcc8
https://pubmed.ncbi.nlm.nih.gov/11301838

Zobrazit plný text záznamu

A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

Autor: H C, Pitot, J A, Knost, M R, Mahoney, J, Kugler, J E, Krook, A K, Hatfield, D J, Sargent, R M, Goldberg

Publikováno v: Cancer. 89(8)

Topoisomerase I inhibitors have demonstrated clinical activity in patients with metastatic colorectal carcinoma. The authors performed a Phase II study to evaluate the objective tumor response rate of 2 different doses and schedules of 9-aminocamptot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9db1372a9e9009ef4ac61beb0c0f8135
https://pubmed.ncbi.nlm.nih.gov/11042563

Zobrazit plný text záznamu

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

Autor: H C, Pitot, R M, Goldberg, J M, Reid, J A, Sloan, P A, Skaff, C, Erlichman, J, Rubin, P A, Burch, A A, Adjei, S A, Alberts, L J, Schaaf, G, Elfring, L L, Miller

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(6)

A Phase I study was performed to determine the maximum tolerated dose (MTD), toxicities, and pharmacokinetic profile of irinotecan (CPT-11) and its active metabolites when given on a once-every-3-week schedule. Thirty-four patients with advanced refr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dc54ff898c143cde0eaba867dc1758d9
https://pubmed.ncbi.nlm.nih.gov/10873073

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání